Cosio F G, Alamir A, Yim S, Pesavento T E, Falkenhain M E, Henry M L, Elkhammas E A, Davies E A, Bumgardner G L, Ferguson R M
Department of Internal Medicine, Ohio State University, Columbus, USA.
Kidney Int. 1998 Mar;53(3):767-72. doi: 10.1046/j.1523-1755.1998.00787.x.
Patients on dialysis and recipients of renal transplants have higher mortality than individuals without kidney disease. In this study we evaluated the possible impact of dialysis therapy before transplantation on patient survival after the transplant. This analysis includes all of the patients who received a cadaveric renal transplant at The Ohio State University from 1984 to 1991 and who remained alive with functioning grafts for at least six months after the transplant (N = 523). After a follow-up of 84 +/- 14 months, 28% of the patients died and 23% lost their grafts. By multivariate analysis, reduced patient survival (censored at the time of graft loss) correlated with these pre-transplant variables: Older age (P < 0.0001), the presence of diabetes (P = 0.0002), smoking (P = 0.009), and the length of time on dialysis (P = 0.0002). Thus, 7% of patients who were never dialyzed, 23% of those dialyzed for less than three years, and 44% of patients dialyzed for > or = three years died post-transplant. By Cox regression, patient survival months correlated with time on dialysis pre-transplant (P = 0.0003). The type of dialysis (CAPD vs. hemodialysis) did not correlate with patient survival. Graft survival, censored for patient death, did not correlate with any of these pre-transplant variables. The relationship between time on dialysis and patient mortality is due to at least two factors: (1) transplant recipients who had dialysis for > or = 3 years had higher mortality due to infections (22%) than those who had dialysis for < 3 years (3%, P = 0.01 by X2); and (2) increasing time on dialysis increases the prevalence of both left ventricular hypertrophy (P = 0.008) and cardiomegaly (P = 0.004), and these relationships are statistically independent of other factors that also correlate with the prevalence of cardiovascular disease. In conclusion, increased time on dialysis prior to renal transplantation is associated with decreased survival of transplant recipients.
接受透析治疗的患者和肾移植受者的死亡率高于没有肾脏疾病的个体。在本研究中,我们评估了移植前透析治疗对移植后患者生存的可能影响。该分析纳入了1984年至1991年在俄亥俄州立大学接受尸体肾移植且移植后至少存活6个月且移植肾功能良好的所有患者(N = 523)。经过84±14个月的随访,28%的患者死亡,23%的患者移植肾失功。通过多变量分析,患者生存率降低(在移植肾失功时进行截尾)与这些移植前变量相关:年龄较大(P < 0.0001)、患有糖尿病(P = 0.0002)、吸烟(P = 0.009)以及透析时间长短(P = 0.0002)。因此,从未接受透析的患者中有7%、透析时间少于3年的患者中有23%以及透析时间≥3年的患者中有44%在移植后死亡。通过Cox回归分析,患者生存月数与移植前透析时间相关(P = 0.0003)。透析类型(持续性非卧床腹膜透析与血液透析)与患者生存率无关。因患者死亡进行截尾后的移植肾生存率与这些移植前变量均无关。透析时间与患者死亡率之间的关系至少归因于两个因素:(1)透析≥3年的移植受者因感染导致的死亡率(22%)高于透析时间<3年的受者(3%,卡方检验P = 0.01);(2)透析时间延长会增加左心室肥厚(P = 0.008)和心脏扩大(P = 0.004)的患病率,并且这些关系在统计学上独立于其他也与心血管疾病患病率相关的因素。总之,肾移植前透析时间延长与移植受者生存率降低相关。